Recombinant TSLP (Tezepelumab Biosimilar) antibody

Catalog No. ABIN7795158

The Human Monoclonal anti-TSLP (Tezepelumab Biosimilar) antibody has been validated for FACS and in vivo. It is suitable to detect TSLP (Tezepelumab Biosimilar) in samples from Human.

Quick Overview for Recombinant TSLP (Tezepelumab Biosimilar) antibody (ABIN7795158)

Target: TSLP (Tezepelumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TSLP (Tezepelumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-TSLP (Tezepelumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Tezepelumab Biosimilar, Human TSLP Monoclonal Antibody

Characteristics: The anti-human TSLP monoclonal antibody tezepelumab biosimilar was produced in mammalian cells.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Isotype: IgG2, lambda

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details for TSLP (Tezepelumab Biosimilar)

Target: TSLP (Tezepelumab Biosimilar)

Alternative Name: Tezepelumab Biosimilar

Target Type: Biosimilar